Log in
NYSEAMERICAN:XTNT

Xtant Medical Stock Forecast, Price & News

$0.80
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.71
Now: $0.80
$0.82
50-Day Range N/A
52-Week Range
$0.55
Now: $0.80
$3.50
Volume83,815 shs
Average Volume577,378 shs
Market Capitalization$10.59 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees141
Market Cap$10.59 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
$0.80
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

When is Xtant Medical's next earnings date?

Xtant Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Xtant Medical
.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) released its quarterly earnings results on Monday, August, 3rd. The medical device company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.08. The medical device company had revenue of $10.53 million for the quarter.
View Xtant Medical's earnings history
.

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical's stock reverse split on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

Are investors shorting Xtant Medical?

Xtant Medical saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 22,000 shares, a decrease of 84.4% from the August 15th total of 141,200 shares. Based on an average trading volume of 981,900 shares, the short-interest ratio is currently 0.0 days. Currently, 0.2% of the shares of the company are sold short.
View Xtant Medical's Short Interest
.

Who are some of Xtant Medical's key competitors?

What other stocks do shareholders of Xtant Medical own?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the following people:
  • Mr. Sean E. Browne, Pres ,CEO & Director (Age 54, Pay $665.08k)
  • Mr. Greg Jensen, VP of Fin., CFO & Principal Financial and Accounting Officer (Age 59, Pay $544.16k)
  • Mr. Kevin D. Brandt, Sr. VP & Chief Commercial Officer (Age 54, Pay $629.65k)
  • Ms. Catherine Lundy, VP of HR
  • Mr. Kevin M. O'Dare, VP of Sales - Eastern US

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

Who are Xtant Medical's major shareholders?

Xtant Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Orbimed Advisors LLC (69.94%), Telemetry Investments L.L.C. (1.55%), Bridgeway Capital Management Inc. (1.30%), Berman Capital Advisors LLC (1.07%) and Wedbush Securities Inc. (0.52%).
View institutional ownership trends for Xtant Medical
.

Which major investors are selling Xtant Medical stock?

XTNT stock was sold by a variety of institutional investors in the last quarter, including Telemetry Investments L.L.C..
View insider buying and selling activity for Xtant Medical
.

Which major investors are buying Xtant Medical stock?

XTNT stock was purchased by a variety of institutional investors in the last quarter, including Berman Capital Advisors LLC, Bridgeway Capital Management Inc., Wedbush Securities Inc., and Orbimed Advisors LLC.
View insider buying and selling activity for Xtant Medical
.

How do I buy shares of Xtant Medical?

Shares of XTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $0.80.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $10.59 million. Xtant Medical employs 141 workers across the globe.

What is Xtant Medical's official website?

The official website for Xtant Medical is xtantmedical.com.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.